Brabei Does the adoption of EUCAST susceptibility breakpoints affect the selection of antimicrobials to treat acute community-acquired respiratory tract infections? Initial quality control evaluations for susceptibility testing of dalbavancin BIan investigational glycopeptide with potent Gram-positive activity. Antibiotics analyzed included amikacin, ceftazidime, ciprofloxacin, cefepime, gentamicin, meropenem and piperacillin—tazobactum. Gentamicin is rarely used as monotherapy in treating gram positive bacteria and as such this difference in MIC cut off is unlikely to be clinically significant. Factors influencing broth microdilution antimicrobial susceptibility test results for dalbavancin, a new glycopeptide agent. These accounted for the reduced level of agreement and may require further harmonization between the two breakpoints.
|Published (Last):||22 October 2004|
|PDF File Size:||14.61 Mb|
|ePub File Size:||18.75 Mb|
|Price:||Free* [*Free Regsitration Required]|
Mazujind In spite of the availability of commercial kits for MRSA detection in the market, the Clinical and Laboratory Standards Institute CLSI recommends the use of phenotypic methods, such as the disk diffusion method with oxacillin or with cefoxitin, as well as a serial dilution method with oxacillin. For additional information, visit the CLSI website at www. These changes were shown to improve drug solubility during panel x23 DMSO and drug availability in the well plastic plates Presulting in a more accurate in vitro assessment of telavancin MIC determinations data on file; Theravance, Inc.
Initial quality control evaluations for susceptibility testing of dalbavancin BIan investigational glycopeptide with potent Gram-positive activity. Open in a separate window. Update on the telavancin activity tested against European staphylococcal clinical isolates Advances in MicrobiologyVol.
Furthermore, the borderline value of zone inhibition diameters for cefoxitin might be considered as a risk, and they may give false-susceptible result. Scientific Research An Academic Publisher. There is a version specifically designed for pharmacists to enhance the implementation of M information tailored to their organization.
These antimicrobial profile characteristics have been very well documented in studies performed during drug development or after regulatory approval when applying the previous BMD method — As previously observed with dalbavancin 4 and oritavancin 5the data presented here, using a large collection of clinically relevant z23, shows that the revised BMD method containing the addition of P common to all three lipoglycopeptides provides lower MIC results than those obtained by the previous method, especially when tested against staphylococci and enterococci.
Frozen-form panels produced according to the previously established susceptibility testing method were manufactured, following the previous CLSI recommendations MS23 A total of clinical isolates were included in this study. Jones are employees of JMI Laboratories who receive grant funds to study telavancin and were paid consultants to Theravance in connection with the development of the manuscript. In contrast, when tested against streptococci, the impact of the revised method on the telavancin MIC results was less pronounced, which was similar to those clis for the other lipoglycopeptides Also noteworthy were the 4- to 8-fold-lower telavancin MIC results obtained against S.
It is mm important to mention that although this revised method provides lower MIC determinations for telavancin, the antimicrobial susceptibility profile remains similar to that established by using the previous BMD method 12 cosi, 13— Published ahead of print 14 July MIC result variations and summary of essential agreement rates between dry-form broth microdilution formulation panel Sensititre and revised reference method for telavancin.
The aim of the study described in this paper was to comparatively evaluate the traditional susceptibility testing for MRSA with PCR as the gold standard assay. The previous method generated results against all E.
During the development of dalbavancin, also a lipoglycopeptide, the use of polysorbate 80 P 0. Several Sensititre dry-form broth microdilution panel candidate formulations eight were manufactured and tested simultaneously with the previous and revised frozen-form panels.
This additional evidence supports that P minimizes drug binding to plastic surfaces, rather than acting synergistically with telavancin. The purpose of this study was to fully evaluate telavancin MIC results when using the revised BMD method compared with those obtained by the previous CLSI method when tested against a larger collection of clinically relevant strains.
During the development of this revised method, previous telavancin MIC determinations obtained when P was added only at the latest step bacterial inoculation resulted in MIC values against S.
Abstract The reference broth microdilution BMD antimicrobial susceptibility testing method for telavancin was revised to include dimethyl sulfoxide DMSO as a solvent and diluent for frozen-form panel preparation, following the CLSI recommendations for water-insoluble agents. All telavancin MIC QC s2 obtained by frozen-form panels prepared according to the previous and revised methods were within the ranges published in the MS23 and J documents, respectively 38— However, Streptococcus pneumoniae had MIC 50 results of 0.
Performance standards for antimicrobial susceptibility testing: Environmental Standards and Trade Volume. Related Articles.
Global Laboratory Standards for a Healthier World